EUVIMEDEUVIMED entdecken
Crossref

Macrophage‐to‐Myofibroblast Transition Contributes to Cutaneous Scarring Formation Through the TGF‐β/Smad3 Signaling Pathways

Yuan Jia, Yi Qin, Feng-Lai Yuan, Jie-Hong Shen

Cell Biology International · 2025

DOI: 10.1002/cbin.70002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Yuan Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Integrated Chinese and Western Medicine, Affiliated to Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Smad3 Protein, Myofibroblasts, Macrophages, Transforming Growth Factor beta. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: This study was provided by the Natural Science Foundation of China (81770876) and Social Development Project of Jiangsu Province (BE2022701)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous scarring typically arises after surgery, trauma, and infection, occurring when normal skin tissue is replaced by fibrous tissue during the healing process. Myofibroblasts have been identified as a significant contributor to this scarring. While the differentiation of fibroblasts into myofibroblasts is well‐recognized as essential for wound healing and tissue repair, the mechanisms underlying the macrophage‐myofibroblast transition (MMT) remain largely unexplored. This study aimed to investigate the role and potential mechanisms of MMT in cutaneous scarring. In specimens of hypertrophic scars, keloid and scleroderma, we confirmed the coexistence of MMT markers CD68 and α‐smooth muscle actin (α‐SMA) in areas of skin fibrosis. Additionally, most MMT cells in human cutaneous scar co‐expressed the M2‐type macrophage marker CD206. Fate‐mapping in Lyz2‐Cre/Rosa26‐tdTomato mice further demonstrated that the majority of myofibroblasts in cutaneous scars were derived from bone marrow macrophages. Furthermore, higher levels of TGF‐β were released from scar fibroblasts, which contributed to MMT through the Smad3 pathways. In vivo studies inhibiting Smad3 reduced MMT and scarring. Macrophage depletion with clodronate liposomes also reduced cutaneous scar formation. Our findings indicate that MMT plays a pivotal role in cutaneous scarring through the TGF‐β/Smad3 pathways. Consequently, inhibiting MMT may be a novel strategy for the treatment of cutaneous scarring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smad3 ProteinMyofibroblastsMacrophagesTransforming Growth Factor betaCicatrixAnimalsHumansSignal TransductionMiceSkinKeloidMaleCicatrix, HypertrophicCell DifferentiationFemaleFibroblastsWound HealingMice, Inbred C57BL

Stichwörter der Autor:innen

M2 macrophagesTGF‐β/Smad3cutaneous scaringextracellular matrixmacrophage‐to‐myofibroblast transition

Substanzen

Smad3 ProteinTransforming Growth Factor betaSMAD3 protein, human

Autor:innen und Institutionen

  • Institute of Integrated Chinese and Western Medicine, Affiliated to Jiangnan University, Wuxi, China.
  • The 82nd Hospital of the Chinese People's Liberation Army, Huaian, China.
  • Xuzhou Medical University, Xuzhou, China.
  • Affiliated Hospital of Jiangnan University, Wuxi, China.

Förderung

  • This study was provided by the Natural Science Foundation of China (81770876) and Social Development Project of Jiangsu Province (BE2022701).

Zitieren

APA

Jia, Y., Qin, Y., Yuan, F. L., & Shen, J. H. (2025). Macrophage‐to‐Myofibroblast Transition Contributes to Cutaneous Scarring Formation Through the TGF‐β/Smad3 Signaling Pathways. Cell Biology International. https://doi.org/10.1002/cbin.70002

Vancouver

Jia Y, Qin Y, Yuan FL, Shen JH. Macrophage‐to‐Myofibroblast Transition Contributes to Cutaneous Scarring Formation Through the TGF‐β/Smad3 Signaling Pathways. Cell Biology International. 2025. doi:10.1002/cbin.70002

BibTeX
@article{Jia2025,
  author = {Jia, Yuan and Qin, Yi and Yuan, Feng-Lai and Shen, Jie-Hong},
  title = {Macrophage‐to‐Myofibroblast Transition Contributes to Cutaneous Scarring Formation Through the TGF‐β/Smad3 Signaling Pathways},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.70002}
}
Kostenlos starten →